Got $10 Billion? Don’t blow it cloning a Woolly Mammoth
Colossal Biosciences, a Dallas-based biotechnology and genetic engineering startup valued at $10 billion, has raised $435 million to “de-extinct” the woolly mammoth, a species that hasn’t walked the Earth in over 4,000 years. The company also plans to clone a dodo bird and a Tasmanian tiger.